China Regenerative Medicine International Ltd

08158

Company Profile

  • Business description

    China Regenerative Medicine International Ltd is an investment holding company. The company is engaged in the provision of healthcare products and services. It is engaged in research and development, production and sales of tissue engineering and regenerative medicine products. The business scope of company includes tissue engineering, cosmetics, cell storage, preparation and therapy, hospitals administration and other business division. The segments of the company are Aesthetic medical and beauty services and Medical services. The majority of the company's revenue is derived from its Aesthetic medical and beauty services segment that provides medical beauty products and services. Geographically, the Hong Kong accounts for the majority of the revenue and also has a presence in PRC.

  • Contact

    132 Nathan Road
    Suite 2310-2318, Miramar Tower
    Tsim Sha Tsui
    Kowloon
    HKG

    T: +852 39189000

    https://www.crmi.hk

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    33

Stocks News & Analysis

stocks

Nvidia earns upgrade as AI buildouts accelerate

Demand for AI infrastructure shows no signs of slowing.
stocks

ASX supermarket share outperforms

Supermarket turnaround drives earnings higher.
stocks

Weekly earnings wrap: FMG, WDS, COL and more

A closer look at the final major results from August reporting season.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,294.3032.900.36%
CAC 408,401.1881.310.98%
DAX 4026,569.99202.750.77%
Dow JONES (US)53,559.999.45-0.02%
FTSE 10010,824.2631.720.29%
HKSE25,584.7919.050.07%
NASDAQ26,402.42138.93-0.52%
Nikkei 22566,405.56273.590.41%
NZX 50 Index13,768.18111.87-0.81%
S&P 5007,711.7619.23-0.25%
S&P/ASX 2009,092.3041.000.45%
SSE Composite Index3,952.184.39-0.11%

Market Movers